Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Russell E.N. Becker(Johns Hopkins University), Trinity J. Bivalacqua(University of Pennsylvania), Phillip M. Pierorazio(University of Pennsylvania Health System), Woonyoung Choi(Johns Hopkins University), Jean Hoffman‐Censits(Sidney Kimmel Comprehensive Cancer Center), Michael H. Johnson(Johns Hopkins University), David J. McConkey(Johns Hopkins University), George J. Netto(University of Pennsylvania), Adam C. Reese(Temple University), Andrés Matoso(Johns Hopkins University), Kelly T. Harris(Johns Hopkins University), Aaron Brant(Johns Hopkins University), Mark Schoenberg(Montefiore Medical Center), Max Kates(Duke Medical Center), Alex S. Baras(Sidney Kimmel Comprehensive Cancer Center), Michael J. Biles(Johns Hopkins University), Alexa Meyer(Johns Hopkins University), Noah M. Hahn(Johns Hopkins University)
Cited by 72
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k